An illuminating summary of our current understanding of the interactive role of dopamine and glutamate in psychiatric diseases and the therapeutic strategies and possibilities for future treatment. Among the new ideas presented are hypotheses on the role of dopamine and glutamate in aggression, the glutamate system in anxiety disorders, glutamate and neurodegeneration, and on the origin and progression of Parkinson's disease. Additional chapters offer novel insights into a variety of psychiatric diseases, including ADHD, stress, aggression, addiction, schizophrenia, depression, social phobias, dementias, bulimia, and neurodegenerative diseases like Parkinson's and Alzheimer's diseases. Each chapter summarizes the prevalence and symptoms of the disease and explains the involvement of dopamine and/or glutamate systems using the newer molecular approaches such as transgenic knockout or knockin mice and recent brain imaging techniques.

xii the evaluations, techniques, and outcome have helped to document the efficacy of their therapeutic modalities. In addition, many good books and articles have been published introducing new concepts, such as the importance of systematic case studies and personality styles by Horowitz, a variety of brief therapies by Budman, and an integrating model of time-limited psychotherapy by Strupp, to men tion only a few. The investigation of the efficacy of short-term anxiety-provoking psychotherapy (STAPP), which is the subject of this book, has con tinued during the last eight years, particularly in reference to pa tients with unresolved Oedipal conflicts. The chapter on outcome has therefore been expanded to include some of our findings. Cautious attempts have also been made to utilize focal and in novating techniques for the treatment of individuals with borderline as well as compulsive personalities. In this second edition an effort has been made to present the specific technical factors which seem to have a therapeutic effect, such as problem solving, self-understanding, and new learning, and which are utilized by the patients to solve new emotional conflicts long after the end of their treatment. Chapters on the treatment of elderly patients and the handling of individuals with physical symptomatology have been added; a history of the extensive treatment of a male patient has been pre sented to complement the discussion of the therapy of my female patient which appears in Appendix I."

Electrodennal activity refers to electrical changes across the skin in areas of the body that are psychologically responsive. The eccrine sweat glands are the primary detenninant of electrodennal activity, and these are psychologically active especially on the palms of the hands and the soles of the feet. As a matter of convenience, electrodennal activity is most often recorded from the palms. Over the years, the electrodennal response has been known as the psychogalvanic reflex, the galvanic skin response, the skin resistance response, the skin conductance response, and the skin potential response. The tenns psychogalvanic reflex and galvanic skin response have fallen into disuse among scientists, but are still to be found in psychology text books. of its early discovery, ease of measurement, and often easily observable Because response to experimental manipulations, the recording of electrodennal activity is one of the most frequently used methods in psychophysiology. Indeed, in the early years following the founding of the Society for Psychophysiological Research, electrodennal research so dominated the field that people worried that the society was simply an electrodennal society. Although other psychophysiological techniques have emerged as equally strong contributors to psychophysiology, electrodennal research continues to be important throughout the world. As a result of this massive research investment, there has been great progress in understanding electrodennal phenomena, as well as major advances in recording methods since the phenomenon was discovered.

This book examines the intermediate level of mental health services with a focus on partial hospitalization program (PHP) and intensive outpatient program (IOP) models of care for youth. It reviews the history of PHPs and IOPs and highlights their current care models, demonstrating the increase in the development and implementation of evidence-based treatment (EBT) practices. The book explores issues relating to program development, implementation, and considerations for sustainability. It provides interventions designed to enhance the well-being of youth who are experiencing a range of mental health concerns as well as strategies to engage and involve their families. In addition, the book offers feasible strategies for measuring outcomes and applying these results to meaningful clinical evaluations in PHP and IOP settings. It describes the process of accessing and using these intermediate services as well as additional treatment resources that may be necessary in the continuum of mental health care for youth. Key areas of coverage include: The history and purpose of mental health care and the role of day treatment programs for youth. Working with program administration and other stakeholders, identifying a patient population, and engaging community and referral sources. The importance of family involvement, coordination of care, and simultaneously addressing the transactional relationship between physical and mental health. Transitioning youth from pediatric mental health services into the adult mental health system. Working with a diverse patient population in intermediate treatment programs. Providing practical information for families and practitioners navigating the pediatric mental health continuum of care. The Handbook of Evidence-Based Day Treatment Programs for Children and Adolescents is a must-have resource for researchers, professors, and graduate students as well as clinicians, therapists, course instructors, and other professionals in child and adolescent psychiatry, clinical child and school psychology, social work, counseling, public health, family studies, developmental psychology, pediatrics, and all related disciplines.

Following reviews on sleep physiology, regulation, pharmacology, and the neuronal networks regulating sleep and awakening, as well as a classification of sleep disorders, this book presents a number of major breakthroughs in the treatment of those disorders. These include recently approved drugs for treating insomnia, such as Doxepin; variations on previously approved molecules, e.g. Zolpidem sublingual preparation; or new chemical entities in advanced stages of clinical development, e.g. Orexin antagonists. Further topics discussed include drugs acting on the GABA receptor, such as Lorediplon and Eszopiclone; the treatment of excessive daytime drowsiness with cell therapy and drugs such as Modafinil, Armodafinil and Sodium oxybate; and the use of Tasimelteon in the treatment of circadian sleep disorders.

This book covers wide areas of animal and human psychopharmacology with clinical utility in the treatment of psychiatric and neurological (e.g Alzheimer's disease) disorders. The main theme is to develop a new paradigm for drug discovery that questions the claim that animal models or assays fail adequately to predict Phase 3 clinical trials. A new paradigm is advocated that stresses the importance of intermediate staging points between these extremes that depend on suitable translation of findings from animal studies to Phase 1 or Phase 2 studies utilising experimental medicine.

Evolutionary Psychiatry challenges a medical model which has supplied few effective answers to long-standing conundrums. A comprehensive introduction to the new science of Darwinian Psychiatry, this second edition includes important fresh material on a number of disorders, along with an entirely new chapter on research.
Anthony Stevens and John Price argue that psychiatric symptoms are manifestations of ancient adaptive strategies which are no longer necessarily appropriate but which can best be understood and treated in an evolutionary and developmental context. Particularly important are the Stevens and Price propose to account for the worldwide existence of mood disorders and schizophrenia, as well as offering solutions for such puzzles as paedophilia, sado masochism and the function of dreams.
Readily accessible to both the specialist and non-specialist reader, Evolutionary Psychiatry describes in detail the disorders and conditions commonly encountered in psychiatric practice and shows how evolutionary theory can account for their biological origins and functional nature.

Related link: Free Email Alerting

In this book, the history of the Brazilian Psychiatric Reform is told by one of its main protagonists. In the early 1980s, there were about 80 thousand people admitted to psychiatric hospitals in Brazil, with average lengths of hospital stay of approximately 25 years. The psychiatric reform process that took place in the country was responsible for closing more than 60 thousand beds in mental asylums, most of them characterized by conditions of violence and abandonment.The Brazilian Psychiatric Reform was inspired by the psychosocial care model introduced by psychiatrist Franco Basaglia in Italy and was marked by the broad participation of social movements, such as the anti-asylum movement and other human rights movements. This process gave rise to a model of mental health care based on open-door territorial mental health services, guided by the principle of treatment in liberty, in addition to other strategies of deinstitutionalization. More than a proposal to restructure or modernize the mental health care model, the objective of the Brazilian Psychiatric Reform was the construction of a new social place for the diverse and singular subjective experience of madness. By intending to produce new imaginaries, new social representations and new meanings for these experiences, the Brazilian Psychiatric Reform led to one of the larger experiences of deinstitutionalization in the world and to the large scale implementation of a new model of mental health care in which the old asylum-centric paradigm was replaced by a new democratic psychosocial care model.

In incorporating social process into a model of the dynamics of mental disorders, this text questions the individualistic model favoured in current psychiatric and psychoanalytic theory. While the conventional psychiatric viewpoint seeks the causes of mental illness, Scheff views "the symptoms of mental illness" as the violation of residual rules - social norms so taken for granted that they are not explicitly verbalized. The sociological theory developed by Scheff to account for such behaviour provides a framework for studies reported in subsequent chapters. Two key assumptions emerge: first, that most chronic mental illness is in part a social role; and second, that societal reaction may in part determine entry into that role. Throughout, the sociological model of mental illness is compared and contrasted with more conventional medical and psychological models in an attempt to delineate significant problems for further analysis and research. This third edition has been revised and expanded to encompass the controversy prompted by the first edition, and also to re-evaluate developments in the field. New to this edition are discussions of the use of psychoactive drugs in the treatment of mental illness, changing mental health laws, new social science and psychiatric studies, and the controversy surrounding the labelling theory of mental illness itself.

In incorporating social process into a model of the dynamics of mental disorders, this text questions the individualistic model favoured in current psychiatric and psychoanalytic theory. While the conventional psychiatric viewpoint seeks the causes of mental illness, Scheff views "the symptoms of mental illness" as the violation of residual rules - social norms so taken for granted that they are not explicitly verbalized. The sociological theory developed by Scheff to account for such behaviour provides a framework for studies reported in subsequent chapters. Two key assumptions emerge: first, that most chronic mental illness is in part a social role; and second, that societal reaction may in part determine entry into that role. Throughout, the sociological model of mental illness is compared and contrasted with more conventional medical and psychological models in an attempt to delineate significant problems for further analysis and research. This third edition has been revised and expanded to encompass the controversy prompted by the first edition, and also to re-evaluate developments in the field. New to this edition are discussions of the use of psychoactive drugs in the treatment of mental illness, changing mental health laws, new social science and psychiatric studies, and the controversy surrounding the labelling theory of mental illness itself.

With chapters written by psychoanalytic psychotherapists from across Europe, and from different analytic traditions, this book shows the common thread that weaves through these different traditions and the serious challenges facing psychotherapists dealing with the future adult generations of Europe.

Is Attention Deficit Hyperactivity Disorder (ADHD), the most prevalent neuropsychiatric label in childhood, a valid medical condition? Should we really refer to the millions of children diagnosed with ADHD as children who suffer from the 'diabetes of psychiatry' - a chronic and harmful biological condition that must be treated regularly with powerful psychoactive substances? Building on previous critiques, this thorough, elegant, and mainly courageous book answers these questions through a step-by-step rebuttal of the scientific consensus about ADHD and its first-line treatment with stimulant medications.While maintaining scientific rigor, this book is written in a clear, creative, and flowing way, using colorful examples - some funny, some tragic - which sweep the reader and inspire social change. The book integrates key critiques into one consolidated source, uncovers massive evidence against the efficacy and safety of stimulant medications, and offers principal solutions to this burning socio-educational problem. But most importantly, this book reviews dozens of reliability and validity gaps in the overriding biomedical consensus. It exposes multiple biases and non-parsimonious bandages (unjustified rationalizations) aimed at hiding the scientific holes of the consensus and it redefines ADHD as a non-pathological quality/mode-of-thought that has both weaknesses and strengths. In this way, the book serves as the missing needle required to pierce the over-blown theoretical balloon commonly known as ADHD.

In Disordered Thinking and the Rorschach, James Kleiger provides a thoroughly up-to-date text that covers the entire range of clinical and diagnostic issues associated with the phenomenon of disordered thinking as revealed on the Rorschach. Kleiger guides the reader through the history of psychiatric and psychoanalytic conceptualizations of the nature and significance of different kinds of disordered thinking and their relevance to understanding personality structure and differential diagnosis. He then moves on to thorough reviews of the respective contributions of David Rapaport, Robert Holt, Philip Holzman, and John Exner in conceptualizing and scoring disordered thinking on the Rorschach. These synopses are followed by an equally fascinating examination of less well known research conceptualizations, which, taken together, help clarify the basic interpretive conundrums besetting the major systems.
Finally, having brought the reader to a full understanding of systematic exploration to date, Kleiger enters into a detailed analysis of the phenomenological and psychodynamic aspects of disordered thinking per se. Even experienced clinicians will find themselves challenged to reconceptualize such familiar categories as confabulatory or combinative thinking in a manner that leads not only to new diagnostic precision, but also to a richer understanding of the varieties of thought disturbances with their equally variable therapeutic and prognostic implications.
With Disordered Thinking and the Rorschach, Kleiger has succeeded in summarizing a wealth of experience pertaining to the rigorous empirical detection and classification of disordered thinking. Equally impressive, he has taken full advantage of the Rorschach as an assessment instrument able to capture the richness of personality and thus capable of providing a unique clinical window into those crucially important differences in the quality of thought that patients may evince.

Routledge is now re-issuing this prestigious series of 204 volumes originally published between 1910 and 1965. The titles include works by key figures such asC.G. Jung, Sigmund Freud, Jean Piaget, Otto Rank, James Hillman, Erich Fromm, Karen Horney and Susan Isaacs. Each volume is available on its own, as part of a themed mini-set, or as part of a specially-priced 204-volume set. A brochure listing each title in the International Library of Psychology series is available upon request.

Routledge is now re-issuing this prestigious series of 204 volumes originally published between 1910 and 1965. The titles include works by key figures such asC.G. Jung, Sigmund Freud, Jean Piaget, Otto Rank, James Hillman, Erich Fromm, Karen Horney and Susan Isaacs. Each volume is available on its own, as part of a themed mini-set, or as part of a specially-priced 204-volume set. A brochure listing each title in the "International Library of Psychology" series is available upon request.
This title available in eBook format. Click here for more information.
Visit our eBookstore at: www.ebookstore.tandf.co.uk.

Routledge is now re-issuing this prestigious series of 204 volumes originally published between 1910 and 1965. The titles include works by key figures such asC.G. Jung, Sigmund Freud, Jean Piaget, Otto Rank, James Hillman, Erich Fromm, Karen Horney and Susan Isaacs. Each volume is available on its own, as part of a themed mini-set, or as part of a specially-priced 204-volume set. A brochure listing each title in the "International Library of Psychology" series is available upon request.

First published in 1999. This Volume collates a selection of case histories prepared in three countries by special teams, for use as teaching materials at the International Seminar on Mental Health and Infant Development, 1952. The title is designed for students of child development to better communicate with each other about problems of childcare, education, and mental health. Organized into three parts focusing on cases of British, French and American origin, these are intended to be shared by any group of students or professional workers interested in studying child development.

Routledge is now re-issuing this prestigious series of 204 volumes originally published between 1910 and 1965. The titles include works by key figures such asC.G. Jung, Sigmund Freud, Jean Piaget, Otto Rank, James Hillman, Erich Fromm, Karen Horney and Susan Isaacs. Each volume is available on its own, as part of a themed mini-set, or as part of a specially-priced 204-volume set. A brochure listing each title in the "International Library of Psychology" series is available upon request.

Routledge is now re-issuing this prestigious series of 204 volumes originally published between 1910 and 1965. The titles include works by key figures such asC.G. Jung, Sigmund Freud, Jean Piaget, Otto Rank, James Hillman, Erich Fromm, Karen Horney and Susan Isaacs. Each volume is available on its own, as part of a themed mini-set, or as part of a specially-priced 204-volume set. A brochure listing each title in the "International Library of Psychology" series is available upon request.

Routledge is now re-issuing this prestigious series of 204 volumes originally published between 1910 and 1965. The titles include works by key figures such asC.G. Jung, Sigmund Freud, Jean Piaget, Otto Rank, James Hillman, Erich Fromm, Karen Horney and Susan Isaacs. Each volume is available on its own, as part of a themed mini-set, or as part of a specially-priced 204-volume set. A brochure listing each title in the "International Library of Psychology" series is available upon request.

Routledge is now re-issuing this prestigious series of 204 volumes originally published between 1910 and 1965. The titles include works by key figures such asC.G. Jung, Sigmund Freud, Jean Piaget, Otto Rank, James Hillman, Erich Fromm, Karen Horney and Susan Isaacs. Each volume is available on its own, as part of a themed mini-set, or as part of a specially-priced 204-volume set. A brochure listing each title in the "International Library of Psychology" series is available upon request.

From the 19th Collegium Internationale Neuro-psychopharmacolgicum (CINP) Congress in 1994 comes this long-awaited collection that explores traditional herbal medicines as they relate to the treatment of neuropsychiatric diseases today. Dr. Shigenobu Hanba, co-chair of the symposium, joins together with co-editor Dr. Elliot Richelson and other distinguished scientists from around the world to discuss the role that age-old medicinals can play in modern-day therapy. For clinical and basic scientists alike, Herbal Medicines for Neuropsychiatric Disorders provides a comprehensive overview of the status of traditional herbal medicines as they relate to the treatment of neurospychiatric diseases. It will also serve as a source for detailed information on specific natural products and their constituents, as well as a reference point from which to begin a more in-depth exploration of this fascinating field.
Eastern cultures have been using herbal medicines for centuries and mainstream practitioners in many countries continue to use them as valid and effective forms of therapy for neuropsychiatric disorders. An important exception in Western culture, of course, is the United States, where governmental standards for safety and efficacy often pose obstacles for the speedy approval of drugs based on what some might label folkloric remedies. However, in the U.S. today, scientists are now conducting research with traditional herbal medicines with the belief that they offer enormous possibilities for the discovery of new drugs that would provide the basis of a new and effective psychopharmacology.
Along with detailed information on this research, the readers of Herbal Medicines for Neuropsychiatric Disorders explore ancient cultures to gain a greater perspective on the herbal medicines of Japan, China and India. Further reading offers chemical and pharmacological studies of various herbal medicines, as well as reports of studies in which behavioral and biochemical effects of various herbal preparations were tested on senescence-acclerated mice.